ArticleNature communications2025

Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer.

Tao Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.